 Oral melanotic macules patients human immunodeficiency virus group patients seropositive human immunodeficiency virus HIV years time lesions oral mucosa lesions cases diffuse others patients macules surgical excision patients macules administration zidovudine Clinical laboratory evidence adrenal insufficiency patients histologic appearances melanotic macules ultrastructural alterations melanocytes macules Epstein-Barr virus case normal oral mucosa Epstein-Barr virus epithelial cells control group health care workers risk category intravenous drug abusers seronegative HIV Oral melanotic pigmentation control difference significant study oral macules HIV-infected patients clinical behavior lesions different course HIV infection HIV-infected patients cause macules administration zidovudine antifungal antibacterial drugs others cause unknown due multiple factors